Media Releases

2019

22/02/2019

US patent for identifying drugs for abnormal kidney function

24/01/2019

PromarkerD US market update

2018

26/11/2018

Proteomics signs PromarkerD agreement with US big pharma

09/11/2018

PromarkerD kit version complete- commercial release imminent

24/10/2018

Diabetic kidney disease test enters Europe & Export Award

17/10/2018

Proteomics receives $834k in R&D Tax Incentive

05/10/2018

Proteomics receives $928k from sale of shareholding in CPR

19/09/2018

Proteomics & Atturos partner to target diagnostics in Europe

12/09/2018

Proteomics to receive $928k from sale of shareholding in CPR

23/08/2018

Diagnostics Update – the Promarker pipeline

17/07/2018

Proteomics secures major contract – nears cash flow positive

22/06/2018

Proteomics at ADA Diabetes Conference

20/06/2018

Proteomics signs deal with Patia for PromarkerD in Mexico

29/05/2018

Proteomics International signs deal to launch PromarkerD test for diabetic kidney disease in USA

19/04/2018

Europe PromarkerD patent granted for diabetic kidney disease

Newsroom

News Archive

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Subscribe
  • This field is for validation purposes and should be left unchanged.
Menu